Not to worry. I’m happy to write about any drugmaker as much as another - and any issue is of interest, from research, financing and exec changes to marketing, lobbying and, yes, conflicts of interest. Do a search and you’ll see I try to cover as many bases as possible.

And I realize you were using a little saracasm but for the record, I can count 9 full posts about, or mentioning, Sanofi during the past month. That’s not including other links contained in the ‘Pharmlot, Pharmalittle’ round-ups. So Sanofi gets its share. And that Ambien ad has been there a while, actually.

Poking and prodding aside, I didn’t invent the conflicts issue, and I doubt I will solve it. But I do try to highlight issues of interest. Some issues are interpreted as nothing but criticism. I’ve always said I prefer to view these as areas for improvement.

And as I’ve indicated to others - publicly and privately - I’ve longed lived and worked smack in the middle of big pharma territory. Friends, neighbors, even family, work for or with big pharma, in some capacity. Then there’s the broader economic impact on my environs.

I enjoy the sarcasm. That’s fine. But please keep in mind, I try to view the industry - which I’ve been writing about for 12 years now - from various perspectives.

And finally, I’m pleased to legitimate ads, if only because that means the site has a chance to hang around a little longer. But if you come across anything concerning Sanofi, or Ambien, please don’t hesitate to send it my way. Whatever the issue.

Thanks for stopping by,

ed at Pharmalot

I can’t pay attention to the blog entries, as I’m blinded by the Ambien CR advertisements covering the site. I think this may present some sort of conflict of interest. I will be watching to see if the number of postings regarding Sanofi-Aventis falls off as a result of this.